CN Stock MarketDetailed Quotes

Chengda Pharmaceuticals (301201)

Watchlist

41.37
+0.32+0.78%

Market Closed Feb 13 15:00 CST

6.40BMarket Cap-123.86P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chengda Pharmaceuticals (301201) Revenue Breakdown Overview

By Product

Currency:CNY

2025/H1

Stock NameRevenueRatio

自主销售类产品收入109.7M60.13%

定制类产品和服务收入70.35M38.56%

Total special adjustments1.61M0.88%

Other business794.04K0.44%

By Industry

Currency:CNY

2024/FY

Stock NameRevenueRatio

Pharmaceutical manufacturing industry185.46M55.67%

Food manufacturing industry143.23M43.00%

Other business2.28M0.69%

贸易类收入2.15M0.65%

By Country/Region

Currency:CNY

2024/FY

Stock NameRevenueRatio

Domestic223.5M67.09%

Abroad109.63M32.91%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

No. Symbol % Chg